pull down to refresh
10 sats \ 8 replies \ @freetx 21 Feb \ on: The Ozempic Shortage Is Over HealthAndFitness
Great! Blindness for everyone!
?
Did we miss something?
reply
Just standard fear mongering.
I've never prescribed these drugs in my life but on the inpatient side I've seen very few side effects but so many cases of patients who have told me they have lost 50+ pounds and gotten off of multiple other drugs as a result of their weight loss.
Healthy young people and fitness professionals love to virtue signal on social media about the right way to do things but in the real world people have 3 kids, back and knee problems, job stress etc and 90% of people gain the weight back and more after 3 years regardless of fad diet.
reply
In July 2024, a study published in the journal JAMA Ophthalmology found a potential link between semaglutide — the active ingredient in Wegovy and Ozempic — and a rare eye condition called nonarteritic anterior ischemic optic neuropathy (NAION).
reply
yeah i saw that study floating around twitter a few months ago (but admittedly did not read).
Would be curious to see if that association holds with the newer meds. My gut (lowest tier of evidence) from seeing patients who would never give up these and talking to docs who prescribe thinks there is 4-5x or greater benefit over any risks from cardiovascular risks from eliminating being a fatty and controlling diabetes.
reply
gut (lowest tier of evidence) This is great, will start using it! 🙂
reply
Interesting. The question is if the blindness was really caused by the drug, I mean it is known that obesity may lead to diabetes and diabetes to blindness. It could just be that the drugs didn’t really work, the patients developed diabetes…
I can also imagine that some people at Novo Nordisk got nervous by this news 😬
reply
Even if there is a higher association of NAION caused by these drugs, I would want to know how that compares to the greater risk of diabetic retinopathy. I have seen NAION less than a handful of times, whereas I see diabetic retinopathy and other complications of diabetes every day.
Too lazy to look up actual numbers with cited sources but O1 vibe check says:
NAION: Often cited around 2–10 per 100,000 persons per year (for individuals over 50). Diabetic Retinopathy : Multiple large-scale studies (e.g., NHANES in the United States) have reported that anywhere from 20% to 40% (or more) of people with diabetes show some level of retinopathy Putting It All Together:
- NAION in diabetics: Elevated risk vs. non-diabetics, but still a relatively uncommon event.
- Diabetic Retinopathy (and its advanced stages) is very common in long-standing diabetes—often cited as the leading cause of new cases of blindness among working-age adults in many countries.
reply
Totally. I even read somewhere that once someone starts with Ozempic / other peptides, they have to take it for good. Once the treatment is stopped, people will gain the weight back. It was about a year or so for Ozempic.
reply